2017
DOI: 10.3233/jad-161148
|View full text |Cite
|
Sign up to set email alerts
|

Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features

Abstract: Ontologies and terminologies are used for interoperability of knowledge and data in a standard manner among interdisciplinary research groups. Existing imaging ontologies capture general aspects of the imaging domain as a whole such as methodological concepts or calibrations of imaging instruments. However, none of the existing ontologies covers the diagnostic features measured by imaging technologies in the context of neurodegenerative diseases. Therefore, the Neuro-Imaging Feature Terminology (NIFT) was deve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2
2
1

Relationship

3
7

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 72 publications
0
10
0
Order By: Relevance
“…Curated data represent molecular (“omics”) entities and their interaction and clinical data (including trial data). A comprehensive, semantic framework representing and formalising knowledge about anatomy (FMA [ 113 ], BRCO [ 114 ], NIF [ 115 ]), about major neurodegenerative diseases (ADO [ 64 ], PDON [ 65 ], MSO [ 116 ]) and about assays and readouts (variables) used in clinical trials (NDD-CTO [ 117 ]; NIFT [ 118 ]; clinicaltrials.gov [ 119 ]) enables “shared semantics” over all scales (from the molecular via the cellular and organ level to the cohort and population level) and all entity types (ranging from genes and proteins to cognitive testing and neuro-imaging).…”
Section: Bioinformatics Methods For the Identification Of Disease mentioning
confidence: 99%
“…Curated data represent molecular (“omics”) entities and their interaction and clinical data (including trial data). A comprehensive, semantic framework representing and formalising knowledge about anatomy (FMA [ 113 ], BRCO [ 114 ], NIF [ 115 ]), about major neurodegenerative diseases (ADO [ 64 ], PDON [ 65 ], MSO [ 116 ]) and about assays and readouts (variables) used in clinical trials (NDD-CTO [ 117 ]; NIFT [ 118 ]; clinicaltrials.gov [ 119 ]) enables “shared semantics” over all scales (from the molecular via the cellular and organ level to the cohort and population level) and all entity types (ranging from genes and proteins to cognitive testing and neuro-imaging).…”
Section: Bioinformatics Methods For the Identification Of Disease mentioning
confidence: 99%
“…Another example is the Alzheimer's Disease Ontology (ADO, see [17]) E ADO or the Neuro-Image Terminology (NIFT, see [18]) E N IF T coming with their hierarchy R ADO , R N IF T . The process of NER will lead to another context relation E hasAnnotation .…”
Section: B Extending the Knowledge Graph Using Nlp-technologiesmentioning
confidence: 99%
“…We will use SCAIView, see [14] or https://www.scaiview.com), an information retrieval system for knowledge discovery for a similar approach. SCAIView was used in many recent research projects, for example regarding neurodegenerative diseases [15], brain imaging features [16] and other theoretic research like document clustering, see [17]. The advantage is, that SCAIView already provides us with Named Entities for MeSH but also other ontological representing biomedical entities.…”
Section: Examplementioning
confidence: 99%